XML 25 R15.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Intangible Assets
9 Months Ended
Sep. 30, 2020
Goodwill and Intangible Assets  
Goodwill and Intangible Assets

8.    Goodwill and Intangible Assets

The following table sets forth the changes in the carrying amount of goodwill (dollars in millions):

BSI Life

Science

BSI NANO

BEST

Total

Balance at December 31, 2019

    

$

84.2

$

208.5

$

0.3

$

293.0

Current period additions

13.3

13.3

Foreign currency impact

4.4

2.1

6.5

Balance at September 30, 2020

$

88.6

$

223.9

$

0.3

$

312.8

As a result of the impact of the COVID-19 pandemic, the Company performed an interim impairment assessment of the goodwill balance as of March 31, 2020 using a combination of both quantitative and qualitative approaches. Based on this interim assessment, the Company concluded the fair values of each of the reporting units were significantly greater than their carrying amounts, and therefore, no impairment is required. The goodwill assessment was based on management's estimates and assumptions, certain of which are dependent on external factors. The Company has performed an assessment as of September 30, 2020 and no further triggering events were identified since March 31, 2020. To the extent actual results differ materially from these estimates, and the risks presented by COVID-19 and the current economic environment persist to negatively affect the Company’s operations in subsequent periods, further interim impairment assessments could be required, which could result in an impairment of goodwill.

The following is a summary of intangible assets, excluding goodwill (dollars in millions):

September 30, 2020

December 31, 2019

Gross

Gross

Carrying

Accumulated

Net Carrying

Carrying

Accumulated

Net Carrying

    

Amount

    

Amortization

    

Amount

    

Amount

    

Amortization

    

Amount

Existing technology and related patents

$

314.4

$

(198.0)

$

116.4

$

300.9

$

(182.4)

$

118.5

Customer relationships

 

144.2

 

(40.7)

 

103.5

 

134.7

 

(30.9)

 

103.8

Non-compete contracts

 

 

 

1.8

(1.8)

Trade names

 

14.8

 

(3.9)

 

10.9

 

13.7

 

(2.9)

 

10.8

Other

0.7

(0.5)

0.2

5.5

(5.4)

0.1

Intangible assets

$

474.1

$

(243.1)

$

231.0

$

456.6

$

(223.4)

$

233.2

For the three months ended September 30, 2020 and 2019, the Company recorded amortization expense of $9.0 million and $9.2 million, respectively, related to intangible assets subject to amortization. For the nine months ended September 30, 2020 and 2019, the Company recorded amortization expense of $26.7 million and $29.2 million, respectively, related to intangible assets subject to amortization.